pRosetta Citations (4)

Originally described in: David Root plasmids
Unpublished

Articles Citing pRosetta

Articles
Creation of Novel Protein Variants with CRISPR/Cas9-Mediated Mutagenesis: Turning a Screening By-Product into a Discovery Tool. Donovan KF, Hegde M, Sullender M, Vaimberg EW, Johannessen CM, Root DE, Doench JG. PLoS One. 2017 Jan 24;12(1):e0170445. doi: 10.1371/journal.pone.0170445. eCollection 2017. PubMed
The Superiority of Sucrose Cushion Centrifugation to Ultrafiltration and PEGylation in Generating High-Titer Lentivirus Particles and Transducing Stem Cells with Enhanced Efficiency. Boroujeni ME, Gardaneh M. Mol Biotechnol. 2018 Mar;60(3):185-193. doi: 10.1007/s12033-017-0044-5. PubMed
Optimization of AsCas12a for combinatorial genetic screens in human cells. DeWeirdt PC, Sanson KR, Sangree AK, Hegde M, Hanna RE, Feeley MN, Griffith AL, Teng T, Borys SM, Strand C, Joung JK, Kleinstiver BP, Pan X, Huang A, Doench JG. Nat Biotechnol. 2020 Jul 13. pii: 10.1038/s41587-020-0600-6. doi: 10.1038/s41587-020-0600-6. PubMed Associated Plasmids pRDA_052 pRDA_112 pRDA_174 pRosetta_v2 Humagne Set C More ...
Benchmarking of SpCas9 variants enables deeper base editor screens of BRCA1 and BCL2. Sangree AK, Griffith AL, Szegletes ZM, Roy P, DeWeirdt PC, Hegde M, McGee AV, Hanna RE, Doench JG. Nat Commun. 2022 Mar 14;13(1):1318. doi: 10.1038/s41467-022-28884-7. PubMed Associated Plasmids pRDA_151 pRDA_152 pRDA_153 pRDA_154 pRDA_155 More ...

If you have published an article using this material, please email us at [email protected] to have your article added to this page.